Liu W, Avent ND, Jones JW, Scott ML, Voak D. Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells. Blood 1999;94:3986–96.10.1182/blood.V94.12.3986
Frohn C, Dümbgen L, Brand JM, Görg S, Luhm J, Kirchner H. Probability of anti-D development in D– patients receiving D+ RBCs. Transfusion 2003;43:893–8.10.1046/j.1537-2995.2003.00394.x12823749
Yazer MH, Triulzi DJ. Detection of anti-D in D– recipients transfused with D+ red blood cells. Transfusion 2007;47:2197– 201.10.1111/j.1537-2995.2007.01446.x17714422
Gonzalez-Porras JR, Graciani IF, Perez-Simon JA, et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D– patients. Transfusion 2008;48:1318–24.10.1111/j.1537-2995.2008.01700.x18422846
McGann H, Wenk RE. Alloimmunization to the D antigen by a patient with weak D type 21. Immunohematology 2010;26: 27–9.10.21307/immunohematology-2019-197
Pham BN, Roussel M, Peyrard T, et al. Anti-D investigations in individuals expressing weak D type 1 or weak D type 2: allo- or autoantibodies? Transfusion 2011;51:2679–85.10.1111/j.1537-2995.2011.03207.x21658048
Ansart-Pirenne H, Asso-Bonnet M, Le Pennec PY, Roussel M, Patereau C, Noizat-Pirenne F. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion 2004;44:1282–6.10.1111/j.1537-2995.2004.04063.x15318849
Legler TJ, Maas JH, Köhler M, et al. RHDsequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 2001;11:383–8.10.1046/j.1365-3148.2001.00327.x11696232
Noizat-Pirenne F, Lee K, Le Pennec P-Y, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002;100: 4223–31.10.1182/blood-2002-01-022912393640
International Society of Blood Transfusion (ISBT). Blood group allele terminology. Available at http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/blood-group-terminology/blood-group-allele-terminology/. Accessed February 14, 2013.
Hemker MB, Ligthart PC, Berger L, van Rhenen DJ, van der Schoot CE, Wijk PA. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 1999;94:4337–42.10.1182/blood.V94.12.4337
Müller TH, Wagner FF, Trockenbacher A, et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001;41: 45–52.10.1046/j.1537-2995.2001.41010045.x11161244
Le Maréchal C, Guerry C, Benech C, et al. Identification of 12 novel RHD alleles in western France by denaturing high-performance liquid chromatography analysis. Transfusion 2007;47:858–63.
Christiansen M, Samuelsen B, Christiansen L, Morbjerg T, Bredahl C, Grunnet N. Correlation between serology and genetics of weak D types in Denmark. Transfusion 2008;48:187–93.
Dogic V, Bingulac-Popovic J, Babic I, et al. Distribution of weak D types in the Croatian population. Transfus Med 2011;21:278–9.10.1111/j.1365-3148.2011.01071.x21269342